Loading clinical trials...
Loading clinical trials...
The purpose of the study is to determine how effective Botox is in reducing the amount of urine leaked and which dose of Botox is more effective and safe in those who have urinary urge incontinence.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University of Rochester
NCT06798311 · Urinary Incontinence (UI), Lower Urinary Tract Symptoms (LUTS), and more
NCT07489794 · Multiple Sclerosis, Urinary Incontinence (UI)
NCT05362292 · Urinary Incontinence, Urge, Urinary Incontinence, and more
NCT07105150 · Urinary Incontinence
NCT07209397 · Overactive Bladder, Overactive Bladder (OAB), and more
University of California at Davis
Sacramento, California
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Duke University Medical Center
Durham, North Carolina
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions